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Recent findings have shown that the blood vessels of different organs exert an active role in regulating organ function.
In detail, the endothelium that aligns the vasculature of most organs is fundamental in maintaining organ homeostasis
and in promoting organ recovery following injury. Mechanistically, endothelial cells (EC) of tissues such as the liver,
lungs or the bone marrow (BM) have been shown to produce “angiocrine” factors that promote organ recovery and
restore normal organ function. Controlled production of angiocrine factors following organ injury is therefore essential
to promote organ regeneration and to restore organ function. However, the molecular mechanisms underlying the
coordinated production and function of such “angiocrine” factors are largely undisclosed and were the subject of the
present study. In detail, we identified for the first time a microRNA (miRNA) expressed by BM EC that regulates the
expression of angiocrine genes involved in BM recovery following irradiation. Using a microarray-based approach, we
identified several miRNA expressed by irradiated BMEC. After validating the variations in miRNA expression by
semi-quantitative PCR, we chose to study further the ones showing consistent variations between experiments,
and those predicted to regulate (directly or indirectly) angiogenic and angiocrine factors. Of the mi-RNA that
were chosen, miR-363-5p (previously termed miR-363*) was subsequently shown to modulate the expression of
numerous EC-specific genes including some angiocrine factors. By luciferase reporter assays, miR-363-5p is shown to
regulate the expression of angiocrine factors tissue inhibitor of metalloproteinases-1 (Timp-1) and thrombospondin 3
(THBS3) at post-transcriptional level. Moreover, miR-363-5p reduction using anti-miR is shown to affect EC angiogenic
properties (such as the response to angiogenic factors stimulation) and the interaction between EC and hematopoietic
precursors (particularly relevant in a BM setting). miR-363-5p reduction resulted in a significant decrease in EC tube
formation on matrigel, but increased hematopoietic precursor cells adhesion onto EC, a mechanism that is shown
to involve kit ligand-mediated cell adhesion. Taken together, we have identified a miRNA induced by irradiation
that regulates angiocrine factors expression on EC and as such modulates EC properties. Further studies on the
importance of miR-363-5p on normal BM function and in disease are warranted.
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Background
The bone marrow (BM) microenvironment consists of
different cell types, grouped in “niches”, defined accord-
ing to the cellular composition and also the signals pro-
duced [1,2]. Detailed knowledge of the regulation and
composition of the BM niches, including the osteoblastic
and the vascular niches, is essential for our understand-
ing of BM function and may also contribute towards the
discovery of therapeutic targets to treat BM diseases.
Emerging evidence suggests the “vascular niche”, and
bone marrow endothelial cells (BMEC) in particular,
conveys signals to hematopoietic progenitor and stem
cells, promoting BM recovery via instructive “angiocrine”
signals that tightly regulate the hematopoietic differ-
entiation process [3,4]. The coordinated production
and release (in such cases) of instructive signals is crucial
for adequate BM recovery and function; hematopoietic dif-
ferentiation and exit into peripheral organs is tightly regu-
lated by the instructive signals from the BM vascular niche
[3,5]. In particular, the communication between BMEC
and hematopoietic elements, namely the hematopoietic
stem and progenitor cells, is crucial for normal BM
function and for maintaining BM integrity following
stress. Whole body irradiation has been used to study
BM turnover, since it rapidly induces BM cells apoptosis
and allows detailed study of the mechanisms involved in
BM cell recovery [6,7]. Whole body irradiation is also clin-
ically relevant as a majority of cancer patients, most not-
ably those suffering from hematological malignancies,
receive some form of radiotherapy [8,9]. Little is known
about the role of miRNAs in the BMEC that contribute to
regulate the BM function and recovery. miRNAs are rec-
ognized post-transcriptional regulators of gene expression
through mRNA targeting and/or translational repression
thereby modulating biological homeostasis [10]. In the
present study, we discovered that miR-363-5p (previously
termed miR-363*) is expressed by EC and is induced by ir-
radiation in vivo and in vitro. miR-363-5p regulates the ex-
pression of angiocrine factors in EC, affects EC angiogenic
properties and also modulates the interaction between EC
and hematopoietic cells.
Results
miRNA expression profile of irradiated whole BM is partially
mirrored on irradiated isolated BMEC
miRNAs were identified on BMEC and on whole BM
after irradiation; we identified 120 miRNAs whose ex-
pression showed similar variations between irradiated
whole BM and BMEC, suggesting these would be mainly
expressed by the latter (Figure 1). miRNA expression from
the microarrays was validated by qRT-PCR on BMEC and
on whole BM samples; we validated the expression of five
miRNAs (Additional files 1 and 2). From the miRNAsselected, miR-363-5p showed the most consistent level
increase considering both microarrays and validation by
qRT-PCR (Figure 1 and Additional file 2). To confirm
that miR-363-5p was induced upon irradiation and to es-
tablish a suitable in vitro system to manipulate, we irradi-
ated primary endothelial cells (HUVEC). We observed a
significant increase in miR-363-5p levels, 24 h after ir-
radiation, by qRT-PCR, accompanied by the increase of
expression of the five miRNAs belonging to the miR-363-
5p cluster (miR-106a, miR-18b, miR-20b, miR-19b-2 and
miR-92a-2) (Figure 2). Taken together, these results
showed that miR-363-5p levels are increased upon irradi-
ation in vivo and in vitro. Moreover, given that levels of
miR-363-5p in resting HUVEC and BMEC are similar
(Additional file 3), but the former are easier to transfect
than the latter, we used HUVEC to perform miR-363-5p
loss- and gain- of function experiments that technically re-
quire high number of cells. Having shown that miR-363-5p
is up-regulated upon irradiation, we next investigated its
role in the regulation of angiogenic and angiocrine-related
genes and EC properties.
Angiogenic and angiocrine factors are regulated
by miR-363-5p
We investigated the angiogenic-related genes modulated
by miR-363-5p on EC reducing the levels of miR-363-
5p (anti-miR-363-5p transfected) and comparing it to
scrambled-transfected controls. As transfection efficiency
of HUVEC can vary (up to 90%, data not shown) the
level of miR-363-5p, specifically the down-regulation
achieved with anti-miR-363-5p, was confirmed by qRT-
PCR (Additional file 4). We analyzed the gene expression
profile of anti-miR-363-5p transfected EC versus scram-
bled controls, using commercially available pre-made PCR
arrays for angiogenesis-related genes and also custom-
made arrays for angiocrine factors as shown in Figures 3A
and 3B, respectively. The gene expression profile analysis
obtained from the angiogenesis-directed pre-made PCR
arrays (Figure 3A) showed that EC with reduced levels
of miR-363-5p had a significant decrease of expression
of pro-angiogenic genes (e.g. ephrin B4 (EPHB4), endo-
glin, FLT1 (VEGFR-1), KDR (VEGFR-2), Notch 4, among
others) and in turn, showed an increase of expression of
anti-angiogenic genes (THBS1, TIMP1). The gene ex-
pression profile was validated by qRT-PCR (Additional
file 5). Additionally, modulation of miR-363-5p in EC
also affected the expression of angiocrine factors. As shown
in Figure 3B, the miR-363-5p reduction led to a general
decrease of the expression of angiocrine genes including
stromal-derived factor 1 (SDF1), Delta ligand-like1, Delta
ligand-like4, CXCR4, angiopoietin2 and angiopoietin-like3.
In turn, an increase of expression of the angiocrine genes,
kit ligand (stem cell factor), jagged-1 and TIMP1 was
observed upon miR-363-5p reduction. Taken together, we
Figure 1 miRNA profiling in bone marrow and bone marrow
endothelial cells. miRNAs differentially expressed (120) in irradiated
BM and BMEC. Only expression values with p < 0.05 were considered.
Unsupervised average linkage hierarchical clustering (Euclidean
distance) was performed. The color display encodes the log2 of the
expression changes, where varying shades of yellow and blue indicate
up and down regulation, respectively.
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sion of both angiogenic and angiocrine genes. However, we
would like to clarify that we cannot, based solely on these
data, conclude the modulated angiogenic and angiocrine
genes are direct targets of miR-363-5p.
TIMP1 is a direct target of miR-363-5p
Having defined candidate genes that appeared to be reg-
ulated by miR-363-5p, next we sought to define if some
were under the direct regulation of miR-363-5p. To
achieve this and as the identification of miRNAs targets
can be complex, we followed a global approach to limit
the search of direct targets of miR-363-5p and modulated
EC with anti-miR-363-5p, pre-miR-363-5p or scramble
control followed by transcriptome analysis using cDNA
microarrays of human genome (Affymetrix GeneChip
Human Gene 1.0 ST array) (Figure 4A). The comparison
of the genes modulated upon miR-363-5p (high/low
levels), and discarding unspecific variations (filtered by
scramble control), in combination with the computa-
tional predictions obtained from miRBase resulted in the
identification of putative 18 target genes, as shown in the
Venn diagram (Figure 4B and Additional file 6). The
known-pathways of the predicted target genes were in-
vestigated using the Ingenuity software, which allowed us
to select genes with a known role in angiogenesis and/or
in the modulation of angiocrine genes (the vascular
niche). The expression of the genes identified from micro-
arrays experiments was further validated by qRT-PCR
(Additional file 7). We validated by qRT-PCR the expres-
sion of four angiocrine genes (TIMP1, SELE, IKBKG and
THBS3), which were considered putative direct targets of
miR-363-5p and thus were selected for further validation
by Luciferase reporter assays. The regulatory 3’UTR of
these four genes was cloned into pMIR-REPORT upstream
the Luciferase gene and co-transfected into HUVEC with
pre-miR-363-5p or scramble control. A specific and direct
interaction between the miRNA and its target (wild-type
UTR) can be assessed by the reduction of the luciferase re-
porter activity following transfection with pre-miR-363-5p.
Conversely, if the miRNA binding site is abrogated (mutant
UTR), the luciferase reporter should be unaffected follow-
ing transfection with pre-miR-363-5p, as the miRNA is no
longer able to recognize the mutated site. According to this
approach, preliminary Luciferase assays using wild-type












































Figure 2 Expression of miR-363-5p cluster in irradiated HUVECs. Expression of the five miRNAs clustered with miR-363-5p in irradiated compared
to non-irradiated endothelial cells, showing an increase of clustered miRNAs 24 h post-irradiation. Error bars represent s.e.m. of the normalized mean
expression of irradiated relative to non-irradiated endothelial cells. * P≤ 0.05 by Student’s t test.
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and TIMP1 are likely regulated by miR-363-5p.
TIMP1 is an inhibitor of matrix metallopeptidases in-
volved in the degradation of the extracellular matrix. The
3’UTR of TIMP1 has two predicted binding sites for miR-
363-5p (Figure 5A). The free energy of the hybrid miR-
NA:3’UTR for TIMP1 is −21.92 Kcal/mol and −15.15
Kcal/mol respectively for site1 and site2. The predicted en-
ergy of the hybrid for TIMP1 (site 1) is lower that −17
Kcal/mol, typical of specific interaction. To prove direct
interaction of miR-363-5p and TIMP1 binding site, site-
directed mutagenesis in the binding sites, specifically in 5
nucleotides of the seed sequence were performed. As a re-
sult, three mutant plasmids were generated comprising the
mutagenesis of the first binding site (MUT1), the second
binding-site (MUT2) or having both binding sites mutated
(MUT1 + 2). As shown in Figure 5B, the increased levels of
miR-363-5p lead to a drastic reduction of the Luciferase/
Renilla activity in the wild-type 3’UTR, suggesting that
miR-363-5p recognizes and interacts with the predicted
binding sites. Conversely, this trend is abolished in all mu-
tants, confirming the specificity of the interaction between
miR-363-5p and TIMP1 3’UTR.
THBS3 contributes to extracellular structure and func-
tion [11], but it remains largely uncharacterized con-
trasting to thrombospondin-1 which well known for its
anti-angiogenic properties. A reduction of Luciferase/
Renilla activity was observed when miR-363-5p levels
are augmented, trend that was reversed with THBS3 mu-
tated 3’ UTR, showing that miR-363-5p regulates THBS3
(Additional file 8). In summary, we show that miR-363-5pregulate two genes involved in extracellular matrix re-
modeling in EC. Importantly, we show that miR-363-5p
regulate the angiocrine gene TIMP1 at post-transcriptional
level.
miR-363-5p modulation affects EC:hematopoietic
precursors communication
We exploited the possibility that miR-363-5p modulation,
since it affected angiocrine factor expression on EC, might
affect also their interaction with hematopoietic progenitor
cells. To investigate the role of miR-363-5p in this process,
we performed an adhesion assay where hematopoietic
progenitor cells (CD34+) were placed in contact with EC
having baseline, reduced or increased miR-363-5p levels.
As shown in Figure 6, co-culture assays of EC and CD34+
cells showed that miR-363-5p reduction increased CD34+
cells adhesion to EC (Figure 6A), increased CD34+ prolif-
eration (Figure 6B) but did not affect the colony-forming
capacity of CD34+ cells on methylcellulose (CFUs) assays
(a measure of the capacity of hematopoietic progeni-
tors to differentiate into different hematopoietic lineages;
Figure 6C). These data show that miR-363-5p modulation
in EC promotes hematopoietic progenitors adhesion and
proliferation. Next, we sought to identify the possible
mechanisms modulated by miR-363-5p that could explain
these observations. We observed that among the differ-
ent angiocrine genes modulated by miR-363-5p in EC,
kit ligand (also termed stem cell factor, SCF) was sig-
nificantly induced by miR-363-5p reduction, as determined
by qRT-PCR (Figure 3B) and also from cDNA microarrays
data (data not shown). Although SCF is not predicted to be

























Figure 3 Modulation of angiogenic and angiocrine genes by miR-363-5p. (A) Expression profile of angiogenesis-related genes of EC with reduced
level of miR-363-5p using pre-made PCR arrays. Unsupervised average linkage hierarchical clustering (Euclidean distance) was performed. The color
display encodes the log2 of the expression changes normalized to scramble control, where varying shades of yellow and blue indicate up and
down regulation, respectively. (B) Expression levels (log2 fold change) of angiocrine genes in endothelial cells having reduced or high levels of
miR-363-5p compared to scramble control. Error bars represent s.e.m. of normalized expression mean. * P≤ 0.05 ** P≤ 0.01 by Student’s t test.
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upon changes in miR-363-5p levels in EC. Considering the
relevant role of SCF in the communication between EC
and hematopoietic precursor cells, soluble SCF was quanti-
fied in the supernatant of EC transfected with anti-miR-
363-5p, pre-miR-363-5p or scramble control. As shown in
Figure 6D the reduction of miR-363-5p in EC resulted in
an increase of soluble SCF, whereas increased miR-363-5p
in EC lead to a significant decrease in soluble SCF release.
Importantly, we performed a rescue experiment by adding
recombinant SCF to our co-cultures. The expectation was
that adding SCF might affect the CD34+ precursor cells
and -at least partially- block their adhesion onto EC trans-
fected with anti-miR.363-5p. As shown in Figure 6A,
addition of SCF significantly reduced the number of ad-
herent CD34+ to anti-miR-363-5p transfected EC. This
was accompanied by a massive increase in non-adherent
CD34+ cells in the co-culture supernatants (not shown).Together, these results suggest that miR-363-5p levels in
EC affect the communication with CD34+ hematopoietic
precursors through a mechanism that at least partially,
involves the regulation of SCF expression and availability.
miR-363-5p modulation affects EC angiogenic properties
Having shown that miR-363-5p reduction affected the
expression of angiocrine factors, next we investigated
whether miR-363-5p modulation affected also EC angio-
genic properties. The increase of miR-363-5p levels pro-
moted EC ability to form capillary-like structures on
matrigel and conversely, the miR-363-5p reduction in EC
affected severely their ability to form capillary-like struc-
tures (Figure 7A and B). In contrast, miR-363-5p reduction
promoted EC proliferation, while miR-363-5p increase did
not affect it (Figure 7C and D). Together, these data show
that perturbation of miR-363-5p levels on EC affect endo-
thelial angiogenic properties.
Figure 4 Identification of putative direct targets of miR-363-5p. (A) Schematic view of the strategy to find direct targets of miR-363-5p.
(B) Venn diagram showing the direct putative target genes as the result of comparison of the arrays with computational predictions (miRBase).
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Similar to solid tumors, neo-vessel formation (angiogen-
esis) has been associated with disease progression in
hematological cancers including leukemias and lymph-
omas [12-14]. This structural role of blood vessels in the
BM is therefore linked to the needed increase in nutri-
ents and oxygen to “feed” the expanding malignant cell
clones. Nevertheless, recent evidence suggests BM vessels
may play a more integrative role in the BM microenvir-
onment, providing “instructive” or “angiocrine” cues to
hematopoietic cells, this way maintaining BM homeostasis
[3]. This dynamic interaction between endothelial cells of
BM vessels and hematopoietic elements (immature, undif-
ferentiated precursors and differentiated progeny) should
be tightly regulated, maintaining the balance between ma-
ture and immature hematopoietic cells and contributing
towards BM recovery when needed. Nevertheless, the mo-
lecular signals that regulate angiocrine factor production
and BM function are largely unknown and were the subject
of the present study.
miRNAs are key regulators of gene expression at post-
transcriptional level and are implicated in a wide range
of biological functions including cell proliferation, differ-
entiation, apoptosis, among many others [15]. miRNAs
deregulation is associated with several cancers [16]. The
miRNA expression profiles show that the vast majority
of the miRNAs is down-regulated in many cancers [17].
Interestingly, there has been a significant interest in theidentification of miRNAs that selectively regulate EC
function, namely during tumor angiogenesis. The term
“angiomiRs” was coined a few years ago, to include
the miRNAs that regulate particular EC functions [18].
Nevertheless, to our knowledge, a specific miRNA regu-
lating angiogenic and angiocrine properties on EC was
not reported. We reasoned that the molecular profiling
of BM EC exposed to stress might reveal the genes and
target pathways involved in the homeostatic function of
EC in BM microenvironment. For this, we used a well-
established approach to induce BM stress (which con-
sisted of whole body sub-lethal irradiation), isolated the
EC from irradiated or control BM and discovered a set of
miRNAs that are induced on BMEC following whole body
irradiation. The miRNA profiling of irradiated BMEC re-
vealed a large number of differentially expressed miRNAs
from the non-irradiated control. Subsequent validation of
miRNA induction by irradiation in vitro allowed further
mechanistic studies to be developed.
In detail, we identified one particular miRNA (miR-
363-5p) that is induced by irradiation and selectively regu-
lates EC properties, including the expression of angiocrine
factors that are involved in the communication between
BMEC and hematopoietic precursor cells. Interestingly,
miR-363-5p previously named miR-363* is a miRNA gen-
erated from the upload of the miRNA* strand into RISC,
which confirms the earlier observation that miRNA* are
not always degraded and are active post-transcriptional
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Figure 5 miR-363-5p interaction with TIMP-1 UTR. (A) Schematic view of the TIMP1 construct into pMIR-REPORT showing the two predicted
binding sites in TIMP1 3’UTR. Sequence alignment of miR-363-5p and the 3’UTR TIMP1 is shown. Nucleotide mutations achieved by site-directed
mutagenesis are colored in red. (B) Renilla luciferase activity normalized to Firefly activity of HUVEC 48 h post-transfection with pre-miR-363-5p
relative to scramble control. Relative luciferase activity of wild-type (WT) 3’UTR constructs and mutation in the predicted site 1 (MUT1), site 2
(MUT2) and both sites mutated (MUT1 + 2) are shown. Errors bars are s.e.m. from three independent transfection experiments. * P ≤ 0.05,
*** P ≤ 0.001 by Student’s t test.
Figure 6 Effect of miR-363-5p levels in the communication between endothelial cells:hematopoietic progenitor cells. (A) Adhesion of
CD34+ cells to HUVEC 24 h post-transfection with scramble control, anti-miR-363-5p or pre-miR-363-5p with or without the addition of recombinant
stem cell factor (SCF). Error bars represent s.e.m. of adherent cells average by field (20x magnification) counted by light microscopy in three replicates.
** P≤ 0.01, ***P≤ 0.001 by Student’s t test. (B) Number of colony-forming units on methylcellulose of CD34+ cells after a 24 h exposure to transfected
HUVECs. Total colony number was counted after 7 days on methylcellulose. (C) Number of HUVEC, 48 h post-transfection with scramble control,
anti-miR-363-5p or pre-miR-363-5p. Data represent the average of cell counting (20x magnification) by light microscopy ± s.e.m. in three replicates.
*P ≤ 0.05 by Student’s t test. (D) Detection of SCF levels by ELISA in HUVEC conditioned media 48 h post-transfection with scramble control,
anti-miR-363-5p or pre-miR-363-5p. Data represent the average of the SCF concentration from three transfection experiments ± s.e.m. *P ≤ 0.05 by
Student’s t test.
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Figure 7 Effect of miR-363-5p levels in EC properties. (A) Tube formation assay to measure angiogenesis activity in HUVEC 48 h post-transfection
with anti-miR-363-5p, pre-miR-363-5p and scramble control. Representative phase contrast (20X magnification) and (B) quantification by branch point
index. Data are means ± s.e.m. of the two replicates from two independent experiments. * P≤ 0.05 by Student’s test. (C) Proliferation assessed by positive
staining for phosphorylated histone H3 (red) 48 h post-transfection with anti-miR-363-5p, pre-miR-363-5p and scramble control. Actin cytoskeleton
was stained with phalloidin (green), nuclei, DAPI (blue). Scale bars, 10 μm. (D) Quantification represents the average ± s.e.m. of three independent
transfection experiments.
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by irradiation and was found to modulate the expression of
angiocrine factors. miR-363-5p regulates (directly and
indirectly) the expression and availability of well known
angiocrine and hematopoietic factors (although their
altered expression could, in fact occur as a result of
a feedback response to miR-363-5p modulation per se).
We showed by luciferase reporter assays that miR-363-
5p regulates the expression of TIMP1 and THBS3 at
post-transcriptional level. Variations in the expression
of these targets at the protein level will be addressed
in future studies in our Laboratory, particularly since
THBS3 biological functions are largely unknown, and
thus the effect of its regulation by miR-363-5p and the
relevance for bone marrow homeostasis remains to be
investigated.
As there were no reports in the literature about the
pathways or genes that miR-363-5p could regulate and
as target identification can be complex, we followed a
transcriptome analysis upon forced modulation of the
miR-363-5p levels. This strategy was previously reported
[20] and was particularly useful to narrow-down the
search of direct targets of a given miRNA. As miRNAs
action depends on the miRNA-target stability, the strat-
egy used, although allowed the identification of miRNA
targets can result in the under-estimation of the targets
identified, which can be dozens for a single miRNA
[21]. Importantly, along with the targets directly regu-
lated by miR-363-5p, its function may be enhanced by
indirect mechanisms, as shown with the indirect regula-
tion of kit ligand (stem cell factor). Kit ligand is essentialfor normal BM function and for BM recovery follow-
ing irradiation [22]. In addition, TIMP1 is an inhibitor
of matrix metalloproteinase function [23]. Earlier studies
had shown the activation of MMP9 in the BM micro-
environment tightly regulates the cleavage of kit ligand
from a membrane bound to a soluble form, promot-
ing BM recovery through hematopoietic precursors
mobilization, differentiation and proliferation [24]. In
the present report we show that EC with reduced miR-
363-5p promote hematopoietic precursors adhesion and
expansion, which is accompanied (and may be at least
partially explained) by increased SCF production and re-
lease. The data presented here suggests that regula-
tion of miR-363-5p expression on BMEC may regulate
the availability of SCF in the BM microenvironment,
highlighting the relevance of this particular miRNA in
BM homeostasis.
Conclusions
We provide evidence for the existence of an “angiomiR”
induced by irradiation, the miR-363-5p, that regulates
EC properties including the control of angiocrine factors
production and release. Further studies implicating the
importance of miR-363-5p in angiogenic or angiocrine
situations are warranted.
Methods
Mice irradiation and isolation of BMEC
All animal experiments were performed with the approval
of the Instituto Gulbenkian de Ciência Animal Care Com-
mittee and Review Board. The mice were sub-lethally
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study, FVB mice were used as subjects. miRNA profiling
was performed in whole BM and in BMEC: the whole
BM were extracted after irradiation as previously de-
scribed and mononuclear cells were separated using
Ficoll (Histopaque-1077). The BMEC were isolated using
anti-CD31 fluorescein-conjugated Abs (1:100, Chemicon)
and recovered using fluorescence-activated cell sorting
(Modular Flow Cytometer, Beckman Coulter). Purity of
recovered BMEC was ≥ 95%. Cells were centrifuged and
the pellet was kept in TRIzol for further RNA extraction.
Total BM from non-irradiated and irradiated mice was
also used for RNA extraction as above.
RNA extraction, cDNA and qRT-PCR
Total RNA was extracted using TRIzol Reagent (Invitrogen™)
according manufacturer instructions. mRNA and miRNAs
were quantified according to the two protocols fol-
lowing described: for miRNA quantification, the cDNA
was synthesized from 500 ng of total RNA using the
NCode™ miRNA first-strand synthesis (Invitrogen™).
miRNAs were quantified by quantitative RT-PCR (qRT-
PCR) with SYBR Green (Invitrogen™) using a Universal
qRT-PCR primer provided and primers to target specific
miRNAs. Two μl of diluted cDNA (1:2) were used as
template in 20 μl qRT-PCR reactions with 10 μM of each
primer and 1x Platinum SYBR Green qRT-PCR Super
Mix-UDG. The expression of U6 was used as endogen-
ous control. miRNA levels were calculated using the
comparative method 2^(−ΔΔCt) [27]. To perform the
quantification of coding genes, the cDNA was synthe-
sized from 1 μg of total RNA and random hexamers and
Superscript II (Invitrogen) were used according to manu-
facturers instructions. Two μl of diluted cDNA (1:2) were
used as template in 20 μl qRT-PCR reactions with 10 μM
of each primer and SYBR Green (Applied Biosystems).
The relative mRNA levels were normalized against 18S
rRNA expression and calculated using the comparative
method 2^(−ΔΔCt) [27]. All quantifications were per-
formed with an ABI PRISM 7900HT Sequence Detection
System (Applied Biosystems). Primers used in this study
are available in Additional file 9. All reactions were run
in triplicate.
miRNA profiling
Total RNA was isolated using TRIzol Reagent (Invitrogen).
Quality and quantity of total RNA was analysed using the
Agilent 2100 Bioanalyser (Agilent Technologies) and
NanoDrop 2000. The miRNA profiling was performed
using the miRCURY LNA (locked nucleic acid) V10.0 mi-
croarrays (Exiqon). The labeling was performed according
to manufacturers recommendations using the miRCURY
LNA microRNA Power labeling kit (Exiqon) from1 μg
of total RNA (BMEC and whole BM). The microarraysused for miRNAs expression profiling comprised a total of
1154 probes from the miRBase Sequence Database version
8.0 (http://microrna.sanger.ac.uk) [28,29]. The hybrid-
ized microarrays were washed, dried and scanned using a
dual-laser Agilent Technologies scanner. Scanned images
were analyzed using Feature Extraction Software (Agilent
Technologies), which converts scanner-generated images
into quantitative log2 ratios. Labelling efficiency was evalu-
ated by the signals from the control spike-in capture
probes. Background correction and normalization was
performed using the Local Nearest Neighbour algorithm
Lowess (locally weighted scatterplot smoothing regres-
sion algorithm), which uses multiple local backgrounds
in the neighbourhood of a given spot to serve as back-
ground signal for that feature. Expression values were
presented as log2 ratio of red signal/green signal. Log2
ratio errors and associated p-values, which determine
the probability that a log ratio is significantly different
form zero, were also calculated. The final expression
values of each miRNA correspond to the average of the
quadruplicates spots within the slide. The expression
values were submitted to Nudge algorithm to identify
differentially expressed miRNAs. TIGR Multiple Experi-
ment Viewer software package (MeV version 4.1; [30])
and Excel was used to perform data analysis and visualize
the results.
Bioinformatic integration of mRNA and miRNA
expression data
The miRNA target prediction was performed using data-
bases available online: miRanda and miRBase (http://
microrna.sanger.ac.uk; [28,29], TargetScan (http://www.
targetscan.org; [31], DIANA microT (diana.pcbi.upenn.
edu; [32] and PicTar (http://pictar.mdc-berlin.de; [33].
Cell culture, transfection and functional analyses of miRNAs
Endothelial cells (Human Umbilical Vein Endothelial
Cells - HUVEC) were cultured in EBM-2 complete
medium supplemented with 5% foetal bovine serum (FBS).
Passages older than 6 were not used in the transfection
experiments. The anti-miR-363-5p, pre-miR-363-5p and
scramble control (Ambion) were electroporated using
HUVEC at 70% confluency at final concentration of 50 nM
according to the manufacturers protocol (Nucleofector V
kit VCA-1001; Amaxa). After 12 h, the media was replaced
with fresh media. Experiments were performed 24 h post-
electroporation.
Endothelial in vitro tube formation assay
The HUVEC (100,000 cells per well) transfected with
anti-miR-363-5p or scramble control were seeded on
24-well plate coated with 200 μl of Growth Factor
Reduced Matrigel (BD Biosciences). Branches were quan-
tified after a 16 h incubation at 37°C. Three biological
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graphs were captured at 20x magnification using an
Olympus Microscope.
Immunofluorescence
The HUVEC were fixed 48 h post-transfection with PFA
(2%) for 10 min at room temperature. Cells were washed
twice in PBS 1x and incubated with PBS/0.1%BSA for
30 min at room temperature. Cells were stained with
phalloidin (1 μg/ml) for 30 min at room temperature,
washed and mounted with Vectashield containing DAPI.
Preparations were examined using a fluorescence micro-
scope (Axioplan Microscope, Zeiss).
PCR array
Expression profiles of angiogenesis-related genes were
generated using PCR Arrays (SABiosciences) in accord-
ance with the manufacturers recommendations in an ABI
PRISM 7900HT Sequence Detection System (Applied
Biosystems). The RNA of HUVEC transfected with anti-
miR-363-5p or scramble control was extracted as above
and 1 μg was treated with DNase followed by cDNA syn-
thesis using RT2 First Strand kit (SABiosciences). cDNA
samples were mixed with RT2 qRT-PCR master mix and
distributed across the PCR array 96-well. Fold-change of
each gene from anti-miR-363-5p to scramble control
HUVEC was reported as Log10(2^(−ΔΔCt)). Fold-changes
greater or less than 0 are indicated as up- or down-
regulation, respectively.
CD34+ isolation and adhesion experiment
Mononuclear cells from human cord bloods were sepa-
rated over Ficoll and CD34+ progenitor cells were fur-
ther isolated using magnetic beads (Miltenyi Biotec)
following manufacturers instructions. Purity of the CD34+
was assessed by flow cytometry. CD34+ progenitor cells
(1000 cells) were added to resting HUVEC monolayers
that were previously (24 h before) transfected with anti-
miR-363-5p, pre-miR-363-5p or scramble control on 24-
well plates. As a rescue experiment, to test whether
CD34+ cells adhesion to HUVEC transfected with anti-
miR-363-5p, pre-miR-363-5p or scramble control could
be blocked by increasing the levels of SCF, recombinant
human stem cell factor (Life Technologies) was added
(10 ng/mL).
Adherent CD34+ cells onto HUVEC were counted
manually using a phase-contrast microscope. Triplicates
were used for each experimental condition.
Colony-forming units (CFU) assay
Cord blood-derived CD34+ cells isolated as described
above were assessed for CFU frequency by culturing them
in methylcellulose (R&D Technologies) according to man-
ufacturers instructions. Cells were cultured in triplicate forseven days after which colonies were counted and morpho-
logically analyzed.
Luciferase reporter assay
For the luciferase reporter experiments, the UTRs of
putative miR-363-5p target genes were amplified and
cloned in a luciferase reporter vector (pMIR-REPORT,
Ambion) downstream the luciferase gene. Specifically,
the wild-type UTRs having the miRNA binding(s) sites
were amplified by PCR using primers having SpeI and
HindIII restriction sites. The PCR products and the vec-
tor were then digested with SpeI and HindIII, cloned into
pMIR-REPORT and transformed into E. coli (One-Shot,
Invitrogen). All constructs were verified by sequen-
cing. Resulting plasmids were co-transfected (1.5 μg)
into HUVEC with anti-miR-363-5p or pre-miR-363-5p
or scramble (50 nM) and pRL-SV40 vector (0.5 μg)
(Promega), which contains a Renilla Luciferase gene to
normalize transfection rates. Mutation of seed sequence
of the miRNA-binding site was performed using the Site-
Directed Mutagenesis Kit (Promega) and the mutated
plasmids were used for transfection as above. Primers
used are listed in the Additional file 9. Luciferase activity
was assayed after 48 h using the Dual-Luciferase Re-
porter System (Promega) and was normalized against
Renilla activity. Results represent Luciferase/Renilla ratios
of three independent experiments.
ELISA for Stem Cell Factor (SCF)
The SCF levels were quantified in the supernatants of
HUVEC transfected with anti-miR-363-5p, pre-miR-363-
5p or scramble control, 48 h post-transfection by ELISA
(R&D Systems), according manufacturers guidelines. The
assay was performed twice and error bars represent s.e.m.
of three transfection experiments.
Transcriptomic studies
Gene expression profiles were performed using microar-
rays (Affymetrix GeneChip Human Gene 1.0 ST array)
using total RNA extracted with TRIzol from HUVEC
transfected with anti-miR-363-5p, pre-miR-363-5p or
scramble control. The level of miR-363-5p (upon forced
reduction or increase) was confirmed by qRT-PCR before
performing the microarrays. GeneChip Hybridization
and scanning were performed at Instituto Gulbenkian de
Ciência (http://www.igc.gulbenkian.pt).
Statistical analysis
Experiments were performed at least three times, unless
indicated. Significance was performed using Student’s t
test (p ≤ 0.05) or Anova, where indicated. Graphs show the
standard error of the mean (s.e.m.) using Student’s t test.
Single, double and triple asterisks indicate statistically sig-
nificant differences: * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001.
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Additional file 1: Validation of the miRNA expression data from
microarrays by qRT-PCR. BM non-irradiated control, whole BM and
BMEC isolated according to the mouse BM dysfunction model were used
from two independent experiments. Error bars represent s.e.m. of the
mean expression. ** P ≤ 0.01 *** P≤ 0.001 by Student’s t test.
Additional flie 2: miRNA expression of eight miRNAs recovered
from the microarray data (from Figure 1) throughout the BM
dysfuncton model. Levels were quantified by qRT-PCR in whole bone
marrow seven days after the first, second and third irradiations. Results
confirm the great increase of miR-363-5p levels in the BM after the
third irradiation.
Additional file 3: Levels of miR-363-5p detected by qRT-PCR in
control non-irradiated HUVECs and BMEC. Error bars represent s.e.m.
of the mean expression.
Additional file 4: Silencing levels of miR-363-5p 48 h post-transfection
with anti-miR-363-5p in EC. Results in this graph are indicative as this
quantification was routinely made for the experiments performed in this
study to assess the efficiency of transfection. Error bars represent s.e.m. of the
mean expression. *** P≤ 0.001 by Student’s t test.
Additional file 5: Validation of angiocrine and angiogenic-related
genes by qRT-PCR. Five genes were selected (Notch4, interleukin8 (IL8),
Jag1, KDR (VEGFR2) and Thrombospondin1 (THBS1)). Data represent the
mean ± s.e.m. of the expression from two independent experiments.
Additional file 6: Genes modulated by miR-363-5p in endothelial
cells. Genes were selected from expression arrays (from Figure 4) and
predicted to be direct targets (miRBase) regardless the fold change cutoff.
Genes up-regulated upon miR-363-5p forced reduction (by transfection with
anti-miR-363-5p) and repressed miR-363-5p levels increase (by transfection
with pre-miR-363-5p). Validation by qRT-PCR and NCBI accession are shown.
Highlighted in grey are genes validated by qRT-PCR. n.a.: not applicable,
qRT-PCR not performed.
Additional file 7: Validation of transcriptomic data (Affymetrix
microarrays) by qRT-PCR. Ten genes were selected for validation based
on pathways analyses using the Ingenuity software. Graph shows
expression levels (log2 fold change) of selected genes in endothelial cells
48 h post-transfection with anti-miR-363-5p or pre-miR-363-5p normalized to
scramble control. Error bars represent s.e.m. of normalized expression mean
from three independent transfection experiments.
Additional file 8: miR-363-5p regulates thrombospondin-3 (THBS3).
(A) Schematic view of the THBS3 construct into pMIR-REPORT showing
the predicted binding site in the 3’UTR. Sequence alignment of miR-363-5p
and the 3’UTR THBS3 is shown. Nucleotide mutations achieved by
site-directed mutagenesis are colored in red. (B) Renilla luciferase activity
normalized to Firefly activity of HUVEC 48 h post-transfection with
pre-miR-363-5p relative to scramble control. Relative luciferase activity of
wild-type and mutated 3’UTR constructs are shown. Errors bars are s.e.m.
from three independent transfection experiments. * P≤ 0.05, *** P≤ 0.001
by Student’s t test.
Additional file 9: Sequence of the primers and experimental
application. h, Human; m, Mouse. Sequence of all the miRNAs used in
the study are also shown.
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